ATE485261T1 - Salicylsäurederivate - Google Patents
SalicylsäurederivateInfo
- Publication number
- ATE485261T1 ATE485261T1 AT06829984T AT06829984T ATE485261T1 AT E485261 T1 ATE485261 T1 AT E485261T1 AT 06829984 T AT06829984 T AT 06829984T AT 06829984 T AT06829984 T AT 06829984T AT E485261 T1 ATE485261 T1 AT E485261T1
- Authority
- AT
- Austria
- Prior art keywords
- acid derivatives
- salicylic acid
- ono2
- bearing
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C203/00—Esters of nitric or nitrous acid
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73897805P | 2005-11-23 | 2005-11-23 | |
PCT/EP2006/068417 WO2007060112A1 (en) | 2005-11-23 | 2006-11-14 | Salicylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE485261T1 true ATE485261T1 (de) | 2010-11-15 |
Family
ID=37682661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06829984T ATE485261T1 (de) | 2005-11-23 | 2006-11-14 | Salicylsäurederivate |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080293781A1 (de) |
EP (1) | EP1951653B1 (de) |
JP (1) | JP2009516719A (de) |
AT (1) | ATE485261T1 (de) |
CA (1) | CA2630805A1 (de) |
DE (1) | DE602006017724D1 (de) |
WO (1) | WO2007060112A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008062466A2 (en) * | 2006-10-13 | 2008-05-29 | Reliance Life Sciences Pvt. Ltd. | Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer |
US8822509B2 (en) | 2006-12-29 | 2014-09-02 | The University Of Queensland | Pain-relieving compositions and uses therefor |
FR2921365B1 (fr) * | 2007-09-21 | 2012-10-12 | Servier Lab | Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
AU2009266408C1 (en) * | 2008-07-02 | 2015-12-10 | The University Of Queensland | Pain-relieving compositions of furoxan NO donors and uses thereof |
WO2010081488A1 (en) * | 2009-01-15 | 2010-07-22 | Humanitas Mirasole S.P.A. | Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
IT1398522B1 (it) * | 2010-02-23 | 2013-03-01 | Istituto Oncologico Veneto Irccs | Nuovi derivati furossanici idrosolubili aventi attivita' antitumorale. |
AU2011243947A1 (en) | 2010-04-23 | 2012-12-06 | Piramal Enterprises Limited | Nitric oxide releasing prodrugs of therapeutic agents |
US9688607B2 (en) | 2011-08-15 | 2017-06-27 | Research Foundation Of The City University Of New York | No- and H2S-releasing compounds |
US9844599B2 (en) | 2013-01-21 | 2017-12-19 | Apparao Satyam | Nitric oxide releasing produgs of therapeutic agents |
CN103848795B (zh) * | 2014-03-07 | 2016-08-17 | 山东大学 | 一种1,2,5-噁二唑-2-氧化物组蛋白去乙酰化酶抑制剂及其制备方法和应用 |
CN104592145B (zh) * | 2015-01-15 | 2017-05-17 | 山东大学 | 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用 |
JP7430879B2 (ja) | 2020-01-27 | 2024-02-14 | 学校法人君が淵学園 | アルブミン結合性を有するnoラジカル放出型抗がん剤としてのニトロ化フェニルカルボン酸誘導体 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19515970A1 (de) * | 1995-05-02 | 1996-11-07 | Bayer Ag | Acetylsalicylsäurenitrate |
IT1276071B1 (it) | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
IT1308633B1 (it) | 1999-03-02 | 2002-01-09 | Nicox Sa | Nitrossiderivati. |
IT1318673B1 (it) * | 2000-08-08 | 2003-08-27 | Nicox Sa | Farmaci per le disfunzioni sessuali. |
EP1219306A1 (de) * | 2000-12-29 | 2002-07-03 | Nicox S.A. | Zyklodextrin und NO-abgebende Arzneimittlen enthaltende Zusammensetzungen |
ITMI20011240A1 (it) | 2001-06-13 | 2002-12-13 | Nicox Sa | Farmaci per le vasculopatie |
ITMI20021399A1 (it) * | 2002-06-25 | 2003-12-29 | Nicox Sa | Inibitori della cicloossigenasi 2 |
ITMI20021392A1 (it) | 2002-06-25 | 2003-12-29 | Nicox Sa | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
WO2005030224A1 (en) | 2003-09-26 | 2005-04-07 | Nicox S.A. | Nitrosylated analgesic and/or anti-inflammatory drugs having antiviral activity |
-
2006
- 2006-11-14 AT AT06829984T patent/ATE485261T1/de not_active IP Right Cessation
- 2006-11-14 DE DE602006017724T patent/DE602006017724D1/de active Active
- 2006-11-14 JP JP2008541695A patent/JP2009516719A/ja not_active Withdrawn
- 2006-11-14 US US12/094,655 patent/US20080293781A1/en not_active Abandoned
- 2006-11-14 WO PCT/EP2006/068417 patent/WO2007060112A1/en active Application Filing
- 2006-11-14 EP EP06829984A patent/EP1951653B1/de not_active Not-in-force
- 2006-11-14 CA CA002630805A patent/CA2630805A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE602006017724D1 (de) | 2010-12-02 |
EP1951653A1 (de) | 2008-08-06 |
EP1951653B1 (de) | 2010-10-20 |
JP2009516719A (ja) | 2009-04-23 |
US20080293781A1 (en) | 2008-11-27 |
WO2007060112A1 (en) | 2007-05-31 |
CA2630805A1 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE485261T1 (de) | Salicylsäurederivate | |
EA201170772A1 (ru) | Органические соединения | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
NO20071880L (no) | Diagnostic Compounds | |
TW200732323A (en) | Organic compounds | |
TW200621313A (en) | Pharmaceutical compositions | |
AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
UY32187A (es) | Composiciones farmaceuticas topicas | |
BRPI0620229A8 (pt) | formulação | |
CR9182A (es) | Derivado de quinolina, su uso, preparacion y medicamento que lo contiene | |
EP1831239B8 (de) | Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carbonsäure gamma-lacton und schlüsselzwischenprodukte für dieses verfahren | |
CR9391A (es) | Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
EA200870058A1 (ru) | Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран | |
NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
NO20074528L (no) | Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme | |
ECSP088464A (es) | Compuesto para la inhibición de la apoptosis | |
GB0615105D0 (en) | Novel compounds | |
AR060155A1 (es) | Combinaciones de principios activos con propiedades insecticidas y acaricidas | |
AR063597A1 (es) | Nueva sal | |
ATE537816T1 (de) | Leflunomid enthaltende pharmazeutische zusammensetzungen | |
TW200633717A (en) | Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
ECSP088574A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica | |
MX2009005182A (es) | Derivados de 2-hidroxi-1,3-diamino-propano. | |
EA200870567A1 (ru) | Производные 2-алкокси-3,4,5-тригидроксиалкиламида, их получение, композиции, их содержащие, и применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |